Form 8-K - Current report:
SEC Accession No. 0001213900-21-035058
Filing Date
2021-06-30
Accepted
2021-06-30 16:31:09
Documents
6
Period of Report
2021-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143446-8k_hoththerap.htm 8-K 35916
2 FIRST AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN HOTH TH ea143446ex10-1_hoth.htm EX-10.1 26360
3 SECOND AMENDMENT TO THE EMPLOYMENT AGREEMENT BETWEEN HOTH THERAPEUTICS, INC. AND ea143446ex10-2_hoth.htm EX-10.2 9779
4 FIRST AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN HOTH TH ea143446ex10-3_hoth.htm EX-10.3 9235
5 PRESS RELEASE DATED JUNE 28, 2021 ea143446ex99-1_hoth.htm EX-99.1 11645
6 GRAPHIC ex99-1_001.jpg GRAPHIC 2489
  Complete submission text file 0001213900-21-035058.txt   97822
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 211062320
SIC: 2834 Pharmaceutical Preparations